Oura Buys Counsel Health for $625 Million
The AI-native primary care company will join the wearable maker, which postponed a stock listing that could have raised up to $2.2 billion.
Updated on Nov. 16, 2026 in Healthcare

Live Poll
Would you trust a medical chat service owned by a ring maker for advice?
Oura agreed to acquire Counsel Health for $625 million in cash, subject to adjustments, under a definitive agreement announced November 10, 2026. The deal follows Oura's decision to postpone a stock market listing that could have raised up to $2.2 billion.
Why it matters
The acquisition pushes Oura further into medical care, building on a Counsel service already offered to Oura members since June 2026. Oura cited its company-reported revenue growth as the basis for its confidence in making the purchase.
Oura's quarterly revenue reached $533 million, up 153% from a year earlier, and Oura reached an $11 billion valuation after a $900 million round in October 2025. Counsel Health, which has roughly 70 employees, raised a $25 million Series A about a year ago, and the source does not state how the $625 million price compares to Counsel's valuation.
The players
Oura
Oura is a maker of smart rings that track sleep, activity and health data, and it has reached an $11 billion valuation.
Counsel Health
Counsel Health is an AI-native primary care company backed by Andreessen Horowitz and GV that combines a medical chatbot with licensed physicians.
The details
Oura will buy Counsel Health, an AI-native primary care company that pairs a medical chatbot with licensed physicians, in an all-cash deal. Inside the Oura app, a member's ring data can be brought into a Counsel Health conversation, and users can be handed to a physician when needed. Counsel Health's chief executive, Muthu Alagappan, will become Oura's chief clinical AI officer.
Timeline
June 2026: Counsel's service became available to Oura members.
October 2025: Oura completed a $900 million funding round at an $11 billion valuation.
November 10, 2026: The companies announced a definitive agreement.
Before the end of calendar 2026: The acquisition is expected to close if customary conditions are met.
Market Landscape
The deal reflects a push by consumer wearable makers to bring clinical services in-house rather than rely on outside health providers. By buying a physician-backed AI care company, Oura moves from selling tracking hardware toward providing the medical follow-up that its data can prompt.
Oura members already using Counsel's service can bring their ring data into a physician-backed conversation without leaving the app. Members who want medical care through Oura may see the service expand as the companies add business customers and grow in preventive, urgent and long-term care.
The takeaway
Wearable data is becoming more useful when it connects to a clinician, so readers who track health metrics should watch whether device makers offer real medical follow-up. The deal's closing terms will show how far Oura's medical services extend beyond its current app.
What happens next
The acquisition is expected to close before the end of calendar 2026 if customary conditions are met.
Further reading
For broader context on how medical care is delivered and regulated, see Healthcare coverage on Wisevoter.
Source note: This article includes information reported by Venture Capital Post.
Live Poll
Would you trust a medical chat service owned by a ring maker for advice?






